Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
5.13
-0.05 (-0.97%)
At close: Dec 5, 2025, 4:00 PM EST
5.15
+0.02 (0.39%)
After-hours: Dec 5, 2025, 7:57 PM EST
Sana Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 49.39 | 64.04 | 73.3 | 67.06 | 50.41 | 28.27 | |
| Research & Development | 140.81 | 207.43 | 253.6 | 204.37 | 274.66 | 232.09 | |
| Operating Expenses | 190.2 | 271.47 | 326.9 | 271.43 | 325.07 | 260.36 | |
| Operating Income | -190.2 | -271.47 | -326.9 | -271.43 | -325.07 | -260.36 | |
| Interest & Investment Income | 4.23 | 10.47 | 9.94 | 3.76 | 0.68 | 0.75 | |
| Other Non Operating Income (Expenses) | 5.86 | - | -0.05 | -0.67 | 0.31 | 0.1 | |
| EBT Excluding Unusual Items | -180.12 | -261 | -317.01 | -268.34 | -324.09 | -259.51 | |
| Asset Writedown | -51.01 | -6.4 | -7.01 | -4.5 | - | - | |
| Other Unusual Items | -3.29 | 0.64 | 40.77 | 3.36 | -31.84 | -25.79 | |
| Pretax Income | -234.41 | -266.76 | -283.26 | -269.48 | -355.93 | -285.31 | |
| Net Income | -234.41 | -266.76 | -283.26 | -269.48 | -355.93 | -285.31 | |
| Net Income to Common | -234.41 | -266.76 | -283.26 | -269.48 | -355.93 | -285.31 | |
| Shares Outstanding (Basic) | 243 | 231 | 195 | 188 | 166 | 13 | |
| Shares Outstanding (Diluted) | 243 | 231 | 195 | 188 | 166 | 13 | |
| Shares Change (YoY) | 10.01% | 18.68% | 3.29% | 13.16% | 1178.88% | 165.43% | |
| EPS (Basic) | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 | -21.92 | |
| EPS (Diluted) | -0.96 | -1.16 | -1.46 | -1.43 | -2.14 | -21.92 | |
| Free Cash Flow | -158.85 | -256.58 | -273.61 | -310.93 | -280.92 | -161.85 | |
| Free Cash Flow Per Share | -0.65 | -1.11 | -1.41 | -1.65 | -1.69 | -12.44 | |
| EBITDA | -176.7 | -255.97 | -309.36 | -255.8 | -314 | -254.44 | |
| D&A For EBITDA | 13.5 | 15.5 | 17.54 | 15.63 | 11.07 | 5.92 | |
| EBIT | -190.2 | -271.47 | -326.9 | -271.43 | -325.07 | -260.36 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.